Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to fall 4.16% to -35 cents per share on November 10
Q3'26
Est.
$-0.35
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.01
Q4'25
Beat
by $0.03
Q3'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -37 cents, missing the estimate of -31 cents. With 3.03M shares outstanding, the current market capitalization sits at 4.10B.